Fig. 3From: The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysisForest plot of hazard ratio (HR). Comparison of progression-free survival (PFS) (a) and overall survival (OS) (b) between α-CTLA-4 plus α-PD-1 combination treatment and other treatments. CI: confidence intervalBack to article page